A social media post claims that Moderna’s CEO confessed to creating a COVID vaccine before the pandemic. After fact checking, we found that the claim is false. According to an Instagram post, “Moderna ...

mRESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringes Canada is the fourth jurisdiction to approve mRESVIA ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

A chemical engineering professor at the University of Cincinnati is developing new ways to deliver treatments for infectious ...

Sky News host Gabriella Power discusses the “plummet” in Pfizer and Moderna stocks following RFK Jr clearing a Senate vote ...

MSD and Moderna’s individualised cancer vaccine mRNA-4157 has shown impressive efficacy in a phase 2b trial in skin cancer melanoma, leaving the partners speculating about a possible regulatory ...

Australia’s domestic investment in R&D has declined over the past 15 years, and now sits at 1.66 per cent of GDP — well below ...

Disinformation campaigns targeting the Quad, a partnership between Australia, India, Japan, and the United States, challenge ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare industry ...

Days before President Donald Trump took office a second time, the Department of Health and Human Services granted Moderna $590 million for the development of mRNA vaccines for bird flu and other ...

The independent review by four industry experts, announced in December and led by Australian-born Tesla chair Robyn Denholm, ...

Nasdaq 100, S&P 500, Dow Jones Industrial Average, Cisco Systems Inc. Read Investing.com (Jesse Cohen)'s latest article on Investing.com Australia.